Abbott spinal cord stimulation system approved by FDA

The FDA approved the market’s smallest implantable and rechargeable spinal cord stimulation system, designed by healthcare technology company Abbott. 

Advertisement

The Eterna system has features including an iPhone app, an upgradable platform and the capability to conduct full-body MRI scans, according to a Dec. 19 news release from the company.  

“[Abbott’s low-dose stimulation] was not available on a rechargeable device that was this small and that only needs to be charged a few times a year,” Timothy Deer, MD, president and CEO of the Spine and Nerve Centers of the Virginias in Charleston, W.Va., said in the release. “This makes a big difference in comfort for many patients who now can have access to the best of both worlds.”

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.